Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on
|
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast |
|
|
|
|
|
Q1 Fiscal Year 2025 Results Press Release |
|
|
|
|
|
Q1 Fiscal Year 2025 Conference Call-Live |
|
|
US Toll Free Dial-In Number: |
1-888-506-0062 |
|
International Dial-In Number: |
1-973-528-0011 |
|
Participant Access Code: |
176159 |
|
|
|
|
Q1 Fiscal Year 2025 Conference Call-Replay |
|
|
US Toll Free Dial-In Number: |
1-877-481-4010 |
|
International Dial-In Number: |
1-919-882-2331 |
|
Participant Access Code: |
51641 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-first-quarter-fiscal-year-2025-results-teleconference-and-webcast-to-be-held-on-november-14-2024-302300035.html
SOURCE
